Structures by: Marrone A.
Total: 5
C17H28Cl2N3OPRu
C17H28Cl2N3OPRu
Journal of medicinal chemistry (2008) 51, 21 6773-6781
a=6.6343(13)Å b=20.033(4)Å c=15.188(3)Å
α=90.00° β=97.73(3)° γ=90.00°
[Pt(Me2NCH2CH2NMe2)(C8H7)Cl]
[Pt(Me2NCH2CH2NMe2)(C8H7)Cl]
Dalton transactions (Cambridge, England : 2003) (2013) 42, 19 6840-6851
a=21.7511(17)Å b=11.4643(9)Å c=37.772(3)Å
α=90.00° β=90.00° γ=90.00°
[Pt(Me2NCH2CH2NMe2)(C8H7)Cl]
[Pt(Me2NCH2CH2NMe2)(C8H7)Cl]
Dalton transactions (Cambridge, England : 2003) (2013) 42, 19 6840-6851
a=7.9854(4)Å b=20.2676(10)Å c=9.6517(5)Å
α=90.00° β=97.931(3)° γ=90.00°
C15H25ClN2OPt
C15H25ClN2OPt
Dalton transactions (Cambridge, England : 2003) (2013) 42, 19 6840-6851
a=10.0881(6)Å b=12.1859(6)Å c=13.5748(6)Å
α=90.00° β=90.00° γ=90.00°
C14H22ClN3O2Pt
C14H22ClN3O2Pt
Dalton transactions (Cambridge, England : 2003) (2013) 42, 19 6840-6851
a=27.2807(7)Å b=8.1215(2)Å c=15.6844(4)Å
α=90.00° β=97.4263(19)° γ=90.00°